Judge allows Enoxaparin antitrust suit to go forward
MLex Summary: US District Judge Barbara D. Holmes has denied Momenta Pharmaceuticals and Sandoz’s motions to dismiss claims that they conspired to maintain a monopoly in the generic market for the...To view the full article, register now.
Already a subscriber? Click here to view full article